Targeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale?
about
Sequence Analysis and Phylogenetic Studies of Hypoxia-Inducible Factor-1αAnti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine.Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation.Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck Cancer.A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation
P2860
Targeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale?
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Targeting hypoxia to overcome ...... allenge or clinical fairytale?
@ast
Targeting hypoxia to overcome ...... allenge or clinical fairytale?
@en
type
label
Targeting hypoxia to overcome ...... allenge or clinical fairytale?
@ast
Targeting hypoxia to overcome ...... allenge or clinical fairytale?
@en
prefLabel
Targeting hypoxia to overcome ...... allenge or clinical fairytale?
@ast
Targeting hypoxia to overcome ...... allenge or clinical fairytale?
@en
P2093
P2860
P1476
Targeting hypoxia to overcome ...... allenge or clinical fairytale?
@en
P2093
Juergen Dunst
Marc Delaperriere
Reinhard Depping
René Baumann
P2860
P304
P356
10.1080/14737140.2016.1192467
P577
2016-06-02T00:00:00Z